On this episode of Stock Movers:
- Amazon (AMZN) shares fall after the White House Press Secretary Karoline Leavitt said that the e-commerce company’s reported decision to display the impact of tariffs on pricing was a “hostile” act. The comments from Leavitt came after Punchbowl News reported that the e-commerce giant would “soon” begin displaying the cost of US tariffs on individual products next to the total listed price.
- Honeywell (HON) shares rise after the company raised its full-year guidance for earnings per share, saying it will offset about $500 million in tariff exposure with price changes and other actions to protect its bottom line. Honeywell, which plans to split into three separate companies, will also use a multiprong approach to offsetting the impact from tariffs, it said in an investor presentation.
- Hims & Hers Health (HIMS) shares soar after the company said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms. Through NovoCare, Novo’s new direct-to-consumer pharmacy platform, Hims, LifeMD Inc., and Ro will each sell a month’s supply of Wegovy starting at $499.

On this episode of Stock Movers: - Amazon (AMZN) shares fall after the White House Press Secretary Karoline Leavitt said that the e-commerce company&rsquo;s reported decision to display the impact of tariffs on pricing was a &ldquo;hostile&rdquo; act. The comments from Leavitt came after Punchbowl News reported that the e-commerce giant would &ldquo;soon&rdquo; begin displaying the cost of US tariffs on individual products next to the total listed price. - Honeywell (HON) shares rise after the company raised its full-year guidance for earnings per share, saying it will offset about $500 million in tariff exposure with price changes and other actions to protect its bottom line. Honeywell, which plans to split into three separate companies, will also use a multiprong approach to offsetting the impact from tariffs, it said in an investor presentation. - Hims &amp; Hers Health (HIMS) shares soar after the company said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms. Through NovoCare, Novo&rsquo;s new direct-to-consumer pharmacy platform, Hims, LifeMD Inc., and Ro will each sell a month&rsquo;s supply of Wegovy starting at $499.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Amazon Falls, Honeywell Rises, Hims & Hers Health Surges on Wegovy Deal

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/7884c3e6-22d1-4305-834d-b2ce00eb52f3/transcript